How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1760
https://www.valueinhealthjournal.com/article/S1098-3015(15)03836-X/fulltext
Title : How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03836-X&doi=10.1016/j.jval.2015.09.1760
First page : A550
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 1193
Categories :
Tags :
Regions :
ViH Article Tags :